title: Emerging resistance in Gram-negative pathogens and implications for clinical practice.
abstract: Infectious disease specialists and scientists attending the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston (MA, USA), were updated on the current worldwide picture regarding different aspects of the use of antimicrobial agents and resistance.
authors.affiliation: Universitario Ramón y Cajal, Madrid, Spain. rcanton.hrc@salud.madrid.org
authors.forename: Rafael
authors.initials: R
authors.lastname: Cantón
authors.forename: Joanna
authors.initials: J
authors.lastname: Lumb
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D024901:Drug Resistance, Multiple, Bacterial; D015507:Drugs, Investigational; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D015507:Drugs, Investigational; D001618:beta-Lactamases; C063912:carbapenemase